![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | C07D 401/14 | |
C07D 213/82 | |||
C07D 213/81 | |||
C07D 401/06 | |||
C07D 237/24 | |||
C07D 261/18 | |||
C07D 403/06 |
(11) | Patento numeris | 2846803 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 13722661.9 |
Europos patento paraiškos padavimo data | 2013-05-08 | |
(97) | Europos patento paraiškos paskelbimo data | 2015-03-18 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2017-06-21 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/US2013/040117 |
Data | 2013-05-08 |
(87) | Numeris | WO 2013/169889 |
Data | 2013-11-14 |
(30) | Numeris | Data | Šalis |
201261644318 P | 2012-05-08 | US | |
201261644411 P | 2012-05-08 | US | |
201261645935 P | 2012-05-11 | US | |
201361801544 P | 2013-03-15 | US |
(72) |
PUTMAN, David, US
DASSE, Olivier, US
|
(73) |
Alpharmagen, LLC,
280 Utah Avenue, Suite 275, South San Francisco, CA 94080,
US
|
(54) | ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR ALLOSTERIC MODULATORS, THEIR DERIVATIVES AND USES THEREOF |
ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR ALLOSTERIC MODULATORS, THEIR DERIVATIVES AND USES THEREOF |